Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPCTM in Alveolar Ridge Preservation
NCT06915675Active, not recruiting
- Sponsor
- Saint Joseph's University
- Start
- Aug 2024
- Primary completion
- Feb 2025
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Randomised, open-label trial of LAENNEC in Alveolar ridge resorption (2 arms), sponsored by Saint Joseph's University. Primary endpoints: Linear soft tissue shrinkage at 30 days and Volumetric bone resorption rate at 4 months. Started Aug 2024; status: active, not recruiting.
02
Drugs
LAENNEC
03
Conditions
Alveolar ridge resorption
Beyond the preview
Go deeper on NCT06915675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06915675.